[1]李琦,曾炳芳,王金武.神经病理性疼痛研究进展[J].中国疼痛医学杂志,2007,13(4):244-246.
[2]Bennett GJ. Neuropathic pain: new insights, new interventions. Hosp Pract (1995). 1998;33(10):95-98, 101-104, 107-10 passim.
[3]Vallejo R, Tilley DM, Williams J, et al. Pulsed radiofrequency modulates pain regulatory gene expression along the nociceptive pathway. Pain Physician. 2013;16(5): E601-613.
[4]Han G, Li L, Meng LX. Effects of hyperbaric oxygen on pain-related behaviors and nitric oxide synthase in a rat model of neuropathic pain. Pain Res Manag. 2013;18(3): 137-141.
[5]仲吉英,杨承祥,徐枫,等.鞘内注射右美托咪定对坐骨神经结扎损伤模型大鼠的镇痛作用[J].临床麻醉学杂志,2012,28(9): 916-918.
[6]Szumita PM, Baroletti SA, Anger KE, et al. Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine. Am J Health Syst Pharm. 2007;64(1): 37-44.
[7]陈章玲,曹德权,徐军美,等.右美托咪啶临床应用新进展[J].广东医学,2012,33(2):290-292.
[8]苑进革,陈永学,赵森明,等.右美托咪啶注射液的临床应用进展[J].山东医药,2012,52(44):100-102.
[9]Grewal A. Dexmedetomidine: New avenues. J Anaesthesiol Clin Pharmacol. 2011;27(3):297-302.
[10]Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs. 2000;59(2):263-270.
[11]周汾,李肇端,余剑波.右美托咪啶临床应用研究进展[J].中国中西医结合外科杂志,2013,19(2):215-217.
[12]Kanazi GE, Aouad MT, Jabbour-Khoury SI, et al. Effect of low-dose dexmedetomidine or clonidine on the characteristics of bupivacaine spinal block. Acta Anaesthesiol Scand. 2006; 50(2):222-227.
[13]Shukla D, Verma A, Agarwal A, et al. Comparative study of intrathecal dexmedetomidine with intrathecal magnesium sulfate used as adjuvants to bupivacaine. J Anaesthesiol Clin Pharmacol. 2011;27(4):495-499.
[14]Ishii H, Kohno T, Yamakura T, et al. Action of dexmedetomidine on the substantia gelatinosa neurons of the rat spinal cord. Eur J Neurosci. 2008;27(12):3182-3190.
[15]侯家保,肖兴鹏,夏中元,等.鞘内注射不同剂量右美托咪啶对大鼠的抗伤害效应和脊髓神经毒性[J].中华麻醉学杂志,2011,31(6): 710-713.
[16]Yaksh TL, Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiol Behav. 1976;17(6):1031-1036.
[17]Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988;33(1):87-107.
[18]王一涵,冷玉芳,李娟,等.右美托咪啶对慢性神经病理性痛大鼠脊髓背角神经元凋亡的影响[J].中华麻醉学杂志,2012,32(3): 353-357.
[19]孙瑞卿,王韵,万有,等.神经源性痛的机制研究进展[J].中国疼痛医学杂志,2003,9(2):105-110.
[20]Civantos Calzada B, Aleixandre de Artiñano A. Alpha-adrenoceptor subtypes. Pharmacol Res. 2001;44(3): 195-208.
[21]韩雪娜,冷玉芳,王一涵,等.右美托咪啶对神经病理性痛大鼠脊髓嘌呤受体P2X4mRNA和p38丝裂原活化蛋白激酶mRNA表达的影响[J].中华麻醉学杂志,2012,32(4):440-443.
[22]邢艳红,冷玉芳,王殊秀,等.可乐定与右美托咪定对慢性神经病理性痛大鼠背根神经节生长相关蛋白-43 mRNA表达的影响[J].中华医学杂志,2012,92(7):444-447.
[23]冯惠民,杜平,李廷坤,等.鞘内注射右美托咪啶对大鼠皮下蜜蜂毒诱导所致的持续性痛反应的抑制作用[J].上海医学,2011,34(12): 953-954.
[24]张红星,曹学照,周芳鞘,等.鞘内注射右美托咪啶对小鼠急性炎性痛的影响[J].中华麻醉学杂志,2011,31(12):1458-1460.
[25]梁伟东,陈彦青.右美托咪定及舒芬太尼联合鞘内注射对CCI模型大鼠的镇痛效应[J].中国疼痛医学杂志,2013,19(6): 336-340.
[26]金小高,罗爱林,张广雄.三种大鼠神经病理性疼痛模型的制备和效果比较[J].临床麻醉学杂志,2005,21(5):338-340.
[27]Decosterd I, Woolf CJ. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain. 2000;87(2): 149-158.
[28]Pullen AH, Humphreys P, Baxter RG. Comparative analysis of nitric oxide synthase immunoreactivity in the sacral spinal cord of the cat, macaque and human. J Anat. 1997;191 (Pt 2): 161-175.
[29]曾静波,李文斌,陈晓玲,等.大鼠甲醛炎症性痛过程中脊髓后角NOS的变化及其时间过程[J].中国病理生理杂志,2000,16(10): 1109-1113.
[30]Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000;288(5472):1765-1769.
[31]郭建荣,贾东林,喻君,等.鞘内注射GDNF对神经病理性疼痛大鼠脊髓NO含量和NOS活性的影响[J].中国疼痛医学杂志,2011, 17(13): 171-175.
[32]Makuch W, Mika J, Rojewska E, et al. Effects of selective and non-selective inhibitors of nitric oxide synthase on morphine- and endomorphin-1-induced analgesia in acute and neuropathic pain in rats. Neuropharmacology. 2013;75: 445-457.
[33]Bobadilla NA, Tapia E, Jiménez F, et al. Dexamethasone increases eNOS gene expression and prevents renal vasoconstriction induced by cyclosporin. Am J Physiol. 1999; 277(3 Pt 2):F464-471.
[34]袁维秀,张宏,徐娟,等.鞘内注射氯胺酮对慢性神经痛大鼠脊髓背角一氧化氮合酶的影响[J].中华麻醉学杂志,2004,24(5): 377-379.
[35]Schulte D, Millar J. The effects of high- and low-intensity percutaneous stimulation on nitric oxide levels and spike activity in the superficial laminae of the spinal cord. Pain. 2003;103(1-2):139-150.
[36]Yoon YW, Sung B, Chung JM. Nitric oxide mediates behavioral signs of neuropathic pain in an experimental rat model. Neuroreport. 1998;9(3):367-372.
[37]Wong CS, Cherng CH, Tung CS. Intrathecal administration of excitatory amino acid receptor antagonists or nitric oxide synthase inhibitor reduced autotomy behavior in rats. Anesth Analg. 1998;87(3):605-608.
[38]Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J. 1994;298 ( Pt 2):249-258.
[39]Schmidt HH, Walter U. NO at work. Cell. 1994;78(6):919-925.
[40]周初松,高建章,赵定麟,等. L-精氨酸对大鼠急性脊髓压迫损伤早期局部微循环的影响及其意义[J].中华创伤杂志,1997,13(2): 102-104 .
[41]Micale V, Cristino L, Tamburella A, et al. Enhanced cognitive performance of dopamine D3 receptor "knock-out" mice in the step-through passive-avoidance test: assessing the role of the endocannabinoid/endovanilloid systems. Pharmacol Res. 2010;61(6):531-536.
[42]Whiteside GT, Munglani R. Cell death in the superficial dorsal horn in a model of neuropathic pain. J Neurosci Res. 2001; 64(2): 168-173.
[43]冷玉芳,金海燕.大鼠坐骨神经慢性压迫损伤后脊髓感觉神经元发生非凋亡性细胞程序性死亡[J].中国疼痛医学杂志,2009, 15(1):23-26.
[44]Appleby VJ, Corrêa SA, Duckworth JK, et al. LTP in hippocampal neurons is associated with a CaMKII-mediated increase in GluA1 surface expression. J Neurochem. 2011; 116(4):530-543. |